Insiders · Profile

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER at Compass Therapeutics. Filing since 19 Jun 2020. CIK 0001591464

Company
Date
Role
Action
Shares
Amount
Of holding
27 May 2025
CHIEF EXECUTIVE OFFICER
Bought
10,000
$21.10K
0.2%
10 Mar 2023
CHIEF EXECUTIVE OFFICER
Bought
10,000
$33.70K
0.2%
27 Feb 2023
CHIEF EXECUTIVE OFFICER
Bought
20,000
$79.60K
0.3%
15 Feb 2023
CHIEF EXECUTIVE OFFICER
Bought
20,000
$77.20K
0.3%
31 Jan 2023
CHIEF EXECUTIVE OFFICER
Bought
20,000
$81.00K
0.4%
24 Jan 2023
CHIEF EXECUTIVE OFFICER
Bought
20,000
$83.80K
0.4%
28 Sep 2022
CHIEF EXECUTIVE OFFICER
Bought
10,000
$23.20K
0.2%
26 Sep 2022
CHIEF EXECUTIVE OFFICER
Bought
15,000
$34.05K
0.3%
7 Sep 2022
CHIEF EXECUTIVE OFFICER
Bought
15,000
$45.45K
0.3%
1 Sep 2022
CHIEF EXECUTIVE OFFICER
Bought
15,000
$42.45K
0.3%
17 Aug 2022
CHIEF EXECUTIVE OFFICER
Bought
15,000
$45.75K
0.3%
10 Aug 2022
CHIEF EXECUTIVE OFFICER
Bought
15,000
$39.60K
0.3%
1 Aug 2022
CHIEF EXECUTIVE OFFICER
Bought
15,000
$38.70K
0.3%
21 Jun 2022
CHIEF EXECUTIVE OFFICER
Bought
20,000
$56.00K
0.4%
16 Jun 2022
CHIEF EXECUTIVE OFFICER
Bought
20,000
$46.80K
0.4%
13 Jun 2022
CHIEF EXECUTIVE OFFICER
Bought
30,000
$68.70K
0.6%
6 Jun 2022
CHIEF EXECUTIVE OFFICER
Bought
30,000
$84.90K
0.6%
1 Jun 2022
CHIEF EXECUTIVE OFFICER
Bought
20,000
$60.60K
0.4%
26 May 2022
CHIEF EXECUTIVE OFFICER
Bought
20,000
$60.80K
0.4%
23 May 2022
CHIEF EXECUTIVE OFFICER
Bought
18,355
$49.93K
0.4%
17 May 2022
CHIEF EXECUTIVE OFFICER
Bought
20,215
$49.93K
0.4%
10 May 2022
CHIEF EXECUTIVE OFFICER
Bought
27,836
$50.10K
0.5%
19 Jun 2020
Chief Executive Officer
Bought
97,431
$487.16K
2.2%
23 decisions on file.